Coagulopathy mediated by hepatoenteric ischemia-reperfusion in rabbits: Role of xanthine oxidase

Vance G Nielsen, Brian T. Geary

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Hepatic transplantation may result in coagulopathy caused by the release of mast-cell-derived heparin, and xanthine oxidase (XO) inhibition stabilizes mast cells. Thus, XO inactivation could decrease coagulopathy after hepatoenteric ischemia-reperfusion. Rabbits were fed a standard or XO-inactivating diet before hepatoenteric ischemia for 35 min and before 30 min of reperfusion. Hemostasis was assessed by thrombelastography. Heparin activity was quantified by anti-IIa. XO inactivation resulted in clot formation after reperfusion in all animals, whereas only 37.5% of animals with XO activity clotted (P<0.05). Anti-IIa activity was less in animals at baseline and after reperfusion with XO inactivation (45±5 and 65±5 mU/mL, respectively) compared to animals with XO activity (51±4 and 71±5 mU/mL, respectively) (P<0.05). Clot strength, which was mediated by coagulation proteins, was significantly greater at baseline and after reperfusion in animals with XO inactivation. XO inactivation enhances hemostasis by decreasing circulating heparin activity and increasing coagulation protein function before ischemia-reperfusion.

Original languageEnglish (US)
Pages (from-to)1181-1183
Number of pages3
JournalTransplantation
Volume74
Issue number8
StatePublished - Oct 27 2002
Externally publishedYes

Fingerprint

Xanthine Oxidase
Reperfusion
Ischemia
Rabbits
Heparin
Hemostasis
Mast Cells
Thrombelastography
Liver Transplantation
Proteins
Diet

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Coagulopathy mediated by hepatoenteric ischemia-reperfusion in rabbits : Role of xanthine oxidase. / Nielsen, Vance G; Geary, Brian T.

In: Transplantation, Vol. 74, No. 8, 27.10.2002, p. 1181-1183.

Research output: Contribution to journalArticle

@article{ad915ce4c2144cbe9b7cda974f5db29d,
title = "Coagulopathy mediated by hepatoenteric ischemia-reperfusion in rabbits: Role of xanthine oxidase",
abstract = "Hepatic transplantation may result in coagulopathy caused by the release of mast-cell-derived heparin, and xanthine oxidase (XO) inhibition stabilizes mast cells. Thus, XO inactivation could decrease coagulopathy after hepatoenteric ischemia-reperfusion. Rabbits were fed a standard or XO-inactivating diet before hepatoenteric ischemia for 35 min and before 30 min of reperfusion. Hemostasis was assessed by thrombelastography. Heparin activity was quantified by anti-IIa. XO inactivation resulted in clot formation after reperfusion in all animals, whereas only 37.5{\%} of animals with XO activity clotted (P<0.05). Anti-IIa activity was less in animals at baseline and after reperfusion with XO inactivation (45±5 and 65±5 mU/mL, respectively) compared to animals with XO activity (51±4 and 71±5 mU/mL, respectively) (P<0.05). Clot strength, which was mediated by coagulation proteins, was significantly greater at baseline and after reperfusion in animals with XO inactivation. XO inactivation enhances hemostasis by decreasing circulating heparin activity and increasing coagulation protein function before ischemia-reperfusion.",
author = "Nielsen, {Vance G} and Geary, {Brian T.}",
year = "2002",
month = "10",
day = "27",
language = "English (US)",
volume = "74",
pages = "1181--1183",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Coagulopathy mediated by hepatoenteric ischemia-reperfusion in rabbits

T2 - Role of xanthine oxidase

AU - Nielsen, Vance G

AU - Geary, Brian T.

PY - 2002/10/27

Y1 - 2002/10/27

N2 - Hepatic transplantation may result in coagulopathy caused by the release of mast-cell-derived heparin, and xanthine oxidase (XO) inhibition stabilizes mast cells. Thus, XO inactivation could decrease coagulopathy after hepatoenteric ischemia-reperfusion. Rabbits were fed a standard or XO-inactivating diet before hepatoenteric ischemia for 35 min and before 30 min of reperfusion. Hemostasis was assessed by thrombelastography. Heparin activity was quantified by anti-IIa. XO inactivation resulted in clot formation after reperfusion in all animals, whereas only 37.5% of animals with XO activity clotted (P<0.05). Anti-IIa activity was less in animals at baseline and after reperfusion with XO inactivation (45±5 and 65±5 mU/mL, respectively) compared to animals with XO activity (51±4 and 71±5 mU/mL, respectively) (P<0.05). Clot strength, which was mediated by coagulation proteins, was significantly greater at baseline and after reperfusion in animals with XO inactivation. XO inactivation enhances hemostasis by decreasing circulating heparin activity and increasing coagulation protein function before ischemia-reperfusion.

AB - Hepatic transplantation may result in coagulopathy caused by the release of mast-cell-derived heparin, and xanthine oxidase (XO) inhibition stabilizes mast cells. Thus, XO inactivation could decrease coagulopathy after hepatoenteric ischemia-reperfusion. Rabbits were fed a standard or XO-inactivating diet before hepatoenteric ischemia for 35 min and before 30 min of reperfusion. Hemostasis was assessed by thrombelastography. Heparin activity was quantified by anti-IIa. XO inactivation resulted in clot formation after reperfusion in all animals, whereas only 37.5% of animals with XO activity clotted (P<0.05). Anti-IIa activity was less in animals at baseline and after reperfusion with XO inactivation (45±5 and 65±5 mU/mL, respectively) compared to animals with XO activity (51±4 and 71±5 mU/mL, respectively) (P<0.05). Clot strength, which was mediated by coagulation proteins, was significantly greater at baseline and after reperfusion in animals with XO inactivation. XO inactivation enhances hemostasis by decreasing circulating heparin activity and increasing coagulation protein function before ischemia-reperfusion.

UR - http://www.scopus.com/inward/record.url?scp=0037184342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037184342&partnerID=8YFLogxK

M3 - Article

C2 - 12438967

AN - SCOPUS:0037184342

VL - 74

SP - 1181

EP - 1183

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 8

ER -